Enhancement of DNA Vaccine Potency by Coadministration of a Tumor Antigen Gene and DNA Encoding Serine Protease Inhibitor-6

Cancer Research

Volumn 64, Issue 1, 2004, Pages 400-405

  Kim, Tae Woo ^a   Hung, Chien Fu ^a   Boyd, David A K ^a   He, Liangmei ^a   Lin, Cheng Tao ^a   Kaiserman, Dion ^b   Bird, Phillip I ^b   Wu, T C ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MONASH UNIVERSITY   (Australia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CD4 ANTIGEN; CD8 ANTIGEN; DNA; DNA VACCINE; GAMMA INTERFERON; GRANZYME B; HEAT SHOCK PROTEIN 70; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; PSEUDOMONAS EXOTOXIN; SERINE PROTEINASE INHIBITOR; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURVIVAL; CERCOPITHECIDAE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GENE; IMMUNE RESPONSE; MOUSE; NEOPLASM; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VACCINATION; VIRUS INFECTION; WART VIRUS;

EID: 1642453782     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1475     Document Type: Article

References (26)

1. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D., Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med., 2: 1122-1128, 1996.
2. Porgador, A., Irvine, K. R., Iwasaki, A., Barber, B. H., Restifo, N. P., and Germain. R. N. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med., 188: 1075-1082, 1998.
3. Chen, C. H., Wang, T. L., Hung, C. F., Yang, Y., Young, R. A., Pardoll, D. M., and Wu, T. C. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res., 60: 1035-1042, 2000.
4. Cheng, W. F., Hung, C. F., Chai, C. Y., Hsu, K. F., He, L., Ling, M., and Wu, T. C. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J. Clin. Investig., 108: 669-678, 2001.
5. Hung, C. F., Cheng, W. F., Hsu, K. F., Chai, C. Y., He, L., Ling, M., and Wu, T. C. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res., 61: 3698-3703, 2001.
6. Wu, T. C., Guarnieri, F. G., Staveley-O'Carroll, K. F., Viscidi, R. P., Levitsky, H. I., Hedrick, L., Cho, K. R., August, J. T., and Pardoll, D. M. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Natl. Acad. Sci. USA, 92: 11671-11675, 1995.
7. Kim, T. W., Hung, C. F., Ling, M., Juang, J., He, L., Hardwick, J. M., Kumar, S., and Wu, T. C. Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. J. Clin. Investig., 112: 109-117, 2003.
8. Ronchese, F., and Hermans, I. F. Killing of dendritic cells: a life cut short or a purposeful death? J. Exp. Med., 194: F23-F26, 2001.
9. Medema, J. P., Schuurhuis, D. H., Rea, D., van Tongeren, J., de Jong, J., Bres, S. A., Laban, S., Toes, R. E., Toebes, M., Schumacher, T. N., Bladergroen, B. A., Ossendorp, F., Kummer, J. A., Melief, C. J., and Offringa, R. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med., 194: 657-667, 2001.
10. Sun, J., Ooms, L., Bird, C. H., Sutton, V. R., Trapani, J. A., and Bird, P. I. A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J. Biol. Chem., 272: 15434-15441, 1997.
11. Browne, K. A., Blink, E., Sutton, V. R., Froelich, C. J., Jans, D. A., and Trapani, J. A. Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perform. Mol. Cell. Biol., 19: 8604-8615, 1999.
12. Barry, M., and Bleackley, R. C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol., 2: 401-409, 2002.
13. Bird, C. H., Sutton, V. R., Sun, J., Hirst, C. E., Novak, A., Kumar, S., Trapani, J. A., and Bird, P. I. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol., 18: 6387-6398, 1998.
14. Hirst, C. E., Buzza, M. S., Bird, C. H., Warren, H. S., Cameron, P. U., Zhang, M., Ashton-Rickardt, P. G., and Bird, P. I. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol., 170: 805-815, 2003.
15. Bird. P. I. Regulation of pro-apoptotic leukocyte granule serine proteinases by intracellular serpins. Immunol. Cell Biol., 77: 47-57, 1999.
16. Pike, R. N., Bottomley, S. P., Irving, J. A., Bird, P. I., and Whisstock, J. C. Serpins: finely balanced conformational traps. IUBMB Life, 54: 1-7, 2002.
17. Lin, K. Y., Guarnieri, F. G., Staveley-O'Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., and Wu, T. C. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res., 56: 21-26, 1996.
18. Ji, H., Wang, T. L., Chen, C. H., Pai, S. I., Hung, C. F., Lin, K. Y., Kurman, R. J., Pardoll, D. M., and Wu, T. C. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum. Gene Ther., 10: 2727-2740, 1999.
19. Shen, Z., Reznikoff, G., Dranoff, G., and Rock, K. L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol., 158: 2723-2730, 1997.
20. Ridge, J. P., Di Rosa, F., and Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (Lond.), 393: 474-478, 1998.
21. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
22. Lebedeva, I., Rando, R., Ojwang, J., Cossum, P., and Stein, C. A. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity. Cancer Res., 60: 6052-6060, 2000.
23. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
24. Cheng, E. H., Levine, B., Boise, L. H., Thompson, C. B., and Hardwick, J. M. Bax-independent inhibition of apoptosis by Bcl-XL. Nature (Lond.), 379: 554-556, 1996.
25. Medema, J. P., de Jong, J., Peltenburg, L. T., Verdegaal, E. M., Gorter, A., Bres, S. A., Franken, K. L., Hahne, M., Albar, J. P., Melief, C. J., and Offringa, R. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA, 98: 11515-11520, 2001.
26. Kim, T. W., Hung, C. F., Boyd, D., Juang, J., He, L., Kim, J. W., Hardwick, J. M., and Wu, T. C. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. J. Immunol., in press, 2003.